The Efficacy and Safety of a Combined Alendronate and Calcitriol Agent (Maxmarvil): A Postmarketing Surveillance Study in Korean Postmenopausal Women with Osteoporosis

BACKGROUND: Combined therapy with alendronate and calcitriol may have additive effects on bone density. An observational study was performed to evaluate the efficacy and safety of Maxmarvil, a combinative agent of alendronate (5 mg) and calcitriol (0.5 µg), and to identify factors associated with ef...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Suh, Hee-Won, Kim, Hyun-Ok, Kim, Young Sik, Sunwoo, Sung, Lee, Jung Ah, Lee, Hye-Ree, Kim, Byungsung, Kim, Dae Hyun, Choi, Youn Seon, Cheong, Yoo Seock, Yum, Keunsang, Yang, Yun Jun, Yu, Byung-Yeon, Cho, Chung Hwan, Park, Sat-Byul, Shin, Dong Hyeok
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Academy of Family Medicine 2012
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3526717/
https://ncbi.nlm.nih.gov/pubmed/23267420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4082/kjfm.2012.33.6.346
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados